Draft Guidance Sheds Much Needed Light On MRI-Compatibility
This article was originally published in The Gray Sheet
Executive Summary
FDA proposes methods and tests that industry can use to prove their passive multi-configuration devices are safe to use in magnetic resonance imaging machines (MRI).
You may also be interested in...
Podcast: FDA, Med Institute Studying MRI Safety of Passive Devices
FDA has partnered with the Med Institute, part of Cook Group, to spend the next three years trying to understand what standards could be used to determine whether a device is MRI compatible.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.